96515-79-6

Basic information

• Product Name: 5-Chloro-2-fluorobenzaldehyde
• Synonyms: 3-CHLORO-6-FLUORO BENZALDEHYDE;5-CHLORO-2-FLUOROBENZALDEHYDE;2-FLUORO-5-CHLOROBENZALDEHYDE;Benzaldehyde, 5-chloro-2-fluoro-
• CAS NO: 96515-79-6
• Molecular Formula: C₇H₄ClFO
• Molecular Weight: 158.56
• Product Categories: Aromatic Aldehydes & Derivatives (substituted);Benzaldehyde;Fluorine series
• Mol File: 96515-79-6.mol
• Article Data: 10

Chemical Properties

• Melting Point: 29-32℃
• Boiling Point: 210.092 °C at 760 mmHg
• Flash Point: 95℃
• Appearance: white to light yellow crystal powder
• Density: 1.352 g/cm³
• Vapor Pressure: 0.196mmHg at 25°C
• Refractive Index: 1.5410
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Solubility: soluble in Methanol
• Sensitive: Air Sensitive
• CAS DataBase Reference: 5-Chloro-2-fluorobenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Chloro-2-fluorobenzaldehyde(96515-79-6)
• EPA Substance Registry System: 5-Chloro-2-fluorobenzaldehyde(96515-79-6)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• WGK Germany: 3
• Hazardous Substances Data: 96515-79-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C7H4ClFO/c8-6-1-2-7(9)5(3-6)4-10/h1-4H

Upstream product

• 452-66-4 5-chloro-2-fluorotoluene 
• 768-66-1 2,2,6,6-tetramethyl-piperidine 
• 352-33-0 1-Chloro-4-fluorobenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 394-30-9 5-chloro-2-fluorobenzoic acid 

Downstream Products

• 1162670-00-9 5-chloro-2-(4-methoxy-phenoxy)-benzaldehyde 
• 1329166-83-7 5-chloro-2-(1H-1,2,3-triazol-1-yl)benzaldehyde 
• 1329166-84-8 5-chloro-2-1,2,3-triazol-2-yl-benzaldehyde 
• 1329166-77-9 5-chloro-2-(1H-1,2,4-triazol-1-yl)benzaldehyde 
• 35212-96-5 5-chloro-2-benzo[b]thiophenecarboxylic acid methyl ester 

Relevant articles and documents

ALK5 INHIBITORS

The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.

Treatment of asthma with MEK inhibitors

This invention provides a method of preventing or treating asthma by administering to a patient in need of treatment an effective amount of a selective MEK inhibitor, especially a phenyl amine of Formula I and II:

Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof

The present invention is to provide a compound of the formula: wherein the ring A is an optionally substituted 5- to 6-membered aromatic heterocyclic ring, the ring B an optionally substituted 5- to 6-membered aromatic homocyclic ring or an optionally sub